Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Pierre-Florent Petit; Douglas Daoudlarian; Sofiya Latifyan; Hasna Bouchaab; Nuria Mederos; Jacqueline Doms; Karim Abdelhamid; Nabila Ferahta; Lucrezia Mencarelli; Victor Joo; Robin Bartolini; Athina Stravodimou; Keyvan Shabafrouz; Giuseppe Pantaleo; Solange Peters; Michel Obeid

doi:10.1101/2024.07.12.24310208

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Pierre-Florent Petit, View ORCID ProfileDouglas Daoudlarian, Sofiya Latifyan, Hasna Bouchaab, Nuria Mederos, Jacqueline Doms, Karim Abdelhamid, Nabila Ferahta, Lucrezia Mencarelli, Victor Joo, Robin Bartolini, Athina Stravodimou, Keyvan Shabafrouz, Giuseppe Pantaleo, Solange Peters, Michel Obeid

doi: https://doi.org/10.1101/2024.07.12.24310208

Pierre-Florent Petit

1Medical oncology service, CHU Helora, Rue Ferrer 159, 7100 La Louvière, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Douglas Daoudlarian

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Douglas Daoudlarian

Sofiya Latifyan

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hasna Bouchaab

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nuria Mederos

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jacqueline Doms

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Karim Abdelhamid

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nabila Ferahta

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lucrezia Mencarelli

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Victor Joo

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robin Bartolini

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Athina Stravodimou

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Keyvan Shabafrouz

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giuseppe Pantaleo

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Solange Peters

3Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Oncology, Medical Oncology Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michel Obeid

2Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Department of Medicine, Immunology and Allergy Service, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: michel.obeid@chuv.ch

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted July 12, 2024.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Pierre-Florent Petit, Douglas Daoudlarian, Sofiya Latifyan, Hasna Bouchaab, Nuria Mederos, Jacqueline Doms, Karim Abdelhamid, Nabila Ferahta, Lucrezia Mencarelli, Victor Joo, Robin Bartolini, Athina Stravodimou, Keyvan Shabafrouz, Giuseppe Pantaleo, Solange Peters, Michel Obeid

medRxiv 2024.07.12.24310208; doi: https://doi.org/10.1101/2024.07.12.24310208

Share This Article:

Citation Tools

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

medRxiv 2024.07.12.24310208; doi: https://doi.org/10.1101/2024.07.12.24310208

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (390)
Allergy and Immunology (705)
Anesthesia (197)
Cardiovascular Medicine (2881)
Dentistry and Oral Medicine (327)
Dermatology (247)
Emergency Medicine (432)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1019)
Epidemiology (12617)
Forensic Medicine (10)
Gastroenterology (812)
Genetic and Genomic Medicine (4483)
Geriatric Medicine (409)
Health Economics (717)
Health Informatics (2868)
Health Policy (1059)
Health Systems and Quality Improvement (1057)
Hematology (378)
HIV/AIDS (910)
Infectious Diseases (except HIV/AIDS) (14030)
Intensive Care and Critical Care Medicine (836)
Medical Education (418)
Medical Ethics (115)
Nephrology (466)
Neurology (4245)
Nursing (228)
Nutrition (622)
Obstetrics and Gynecology (796)
Occupational and Environmental Health (727)
Oncology (2225)
Ophthalmology (633)
Orthopedics (255)
Otolaryngology (322)
Pain Medicine (270)
Palliative Medicine (83)
Pathology (490)
Pediatrics (1182)
Pharmacology and Therapeutics (491)
Primary Care Research (487)
Psychiatry and Clinical Psychology (3695)
Public and Global Health (6829)
Radiology and Imaging (1502)
Rehabilitation Medicine and Physical Therapy (876)
Respiratory Medicine (908)
Rheumatology (430)
Sexual and Reproductive Health (434)
Sports Medicine (376)
Surgery (475)
Toxicology (60)
Transplantation (206)
Urology (176)